Erectile Dysfunction Devices Market Expected to Secure Notable Revenue Share during 2022-2028 | Meda Pharmaceuticals, Coloplast, Global Life Technologies, Reflexonic,

Global Erectile Dysfunction Devices Market is estimated to be valued at US$ 1,303.8 million in 2021, and is expected to exhibit a CAGR of 9.5% during the forecast period (2021-2028).

Ongoing clinical trials by different research institutes for testing and safety and efficiency of erectile dysfunction devices are expected to boost the global erectile dysfunction devices market growth over the forecast period. For instance, University Hospital, Ghent, Belgium, initiated a clinical trial in order to study the surgical outcome after implantation of the of the Zephyr ZSI 475 FTM Inflatable Penile Implant in the neophallus after female-to-male sex reassignment surgery. The study is expected to be completed by December 2029.

𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/27

Global Erectile Dysfunction Devices Market – Impact of Coronavirus (COVID – 19) Pandemic

COVID-19 outbreak was first reported on December 31, 2019, in Wuhan, China. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 215.7 million cases and 4.49 million deaths have been reported due to Coronavirus (COVID-19) up till August 29, 2021, across the globe.

The COVID-19 pandemic has affected several markets across the globe and is also expected to hamper the global erectile dysfunction devices market. The COVID-19 pandemic has affected the demand and supply of healthcare products in three main ways; by directly affecting the production and demand; by creating disruptions in distribution channels; and due to its financial impact on firms and financial markets. Many surgeries are currently at halt due to COVID-19 crisis in order to ensure safety of the patients. Supply chain and manufacturing activities in India, China, the U.S., and others have been disrupted due to lockdowns. Whereas, the countries such as Thailand, Indonesia, Singapore, and others are facing problems with transportation of raw materials.

𝐆𝐞𝐭 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: (𝐈𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐅𝐮𝐥𝐥 𝐓𝐎𝐂, 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐓𝐚𝐛𝐥𝐞𝐬 & 𝐅𝐢𝐠𝐮𝐫𝐞𝐬, 𝐂𝐡𝐚𝐫𝐭) @ https://www.coherentmarketinsights.com/insight/request-pdf/27

Key companies are involved in various inorganic growth strategies, in order to gain a competitive advantage in the market. For instance, in in 2017, Veru Inc., a biopharmaceutical company focused on urology and oncology, entered into a distribution and co-promotion agreement with Timm Medical Technologies for PREBOOST (4% benzocaine wipes) for the prevention of premature ejaculation.

Key Takeaways

• The global erectile dysfunction devices market is expected to exhibit a CAGR of 9.5% over the forecast period (2021-2028)
• Among regions, North America is expected to account for major market share over the forecast period (2021-2028) owing rising number of government initiatives. For instance, The Physicians Committee, a nonprofit organization headquartered in the U.S., is creating awareness regarding erectile dysfunction by celebrating January 26 to February 2, every year, as ‘Erectile Dysfunction Acceptance Week’
• Some of the major players operating in the global erectile dysfunction devices market include Boston Scientific Corporation, Coloplast Corp., Zephyr Surgical Implants, Owen Mumford Ltd., Augusta Medical Systems, Storz medical AG, Promedon, The Elator, Timm Medical, and Silimed.